Financial statements Cardinal Pharma
Cash inflows of CARDINAL PHARMA
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Net cash from operating expenses | 210 253,92 | 153 841,78 | 1 326 364,86 |
| Net cash flow from investing activities | 52 768,50 | -226 808,08 | -216 308,54 |
| Net cash flow from financial activities | 289 495,08 | -445 994,03 | -211 535,15 |
| Total net cash flow | 552 517,50 | -518 960,33 | 898 521,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.